Neurocrine Biosciences, Inc.NBIXNASDAQ
Loading
Pre-Tax Margin Over TimeExpanding
Percentile Rank92
3Y CAGR+19.7%
5Y CAGR+19.3%
Studio
Year-over-Year Change

Pre-tax income as a percentage of revenue

3Y CAGR
+19.7%/yr
vs +31.3%/yr prior
5Y CAGR
+19.3%/yr
Consistent
Acceleration
-11.5pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM24.66%+19.5%
202420.63%+17.3%
202317.60%+22.5%
202214.37%+60.6%
20218.95%-12.3%
202010.20%+72.9%
20195.90%+21.9%
20184.84%+105.5%
2017-88.19%+90.6%
2016-940.60%-